AIM: A number of studies have shown that genetic variation at GABRA2 alters vulnerability to alcohol dependence. The exact identity of the causal variant(s), and the relationship of these variants to other forms of substance use and behavioral illness is, however, uncertain. OBJECTIVE: Therefore, we genotyped 516 individuals from the Iowa Adoption Studies, a large longitudinal case and control adoption study of substance use, at 39 single nucleotide polymorphisms encompassing the GABRA2 locus and analyzed them with respect to their lifetime history of three common forms of substance use dependence [alcohol dependence (AD), nicotine dependence (ND), and cannabis dependence (CD)] in the Iowa Adoption Studies and relevant exposure variables. RESULT: Using regression analysis, we found substantial evidence that both GABRA2 genotype and haplotype are significantly related to vulnerability to AD, ND, and CD, with the strongest relationships noted with respect to ND. Consistent with earlier studies suggesting exposure is an important step in the development of substance use, we found the inclusion of substance exposure data in our analytic models markedly increased the strength of the genetic associations of GABRA2 haplotype with substance use. Finally, we report that the genetic effects were markedly more pronounced in females than in males. CONCLUSION: We conclude that genetic variation at or near the GABRA2 locus significantly affects vulnerability not only to AD, but to other forms of substance use including ND and CD, and that the effects may be sex dependent.
AIM: A number of studies have shown that genetic variation at GABRA2 alters vulnerability to alcohol dependence. The exact identity of the causal variant(s), and the relationship of these variants to other forms of substance use and behavioral illness is, however, uncertain. OBJECTIVE: Therefore, we genotyped 516 individuals from the Iowa Adoption Studies, a large longitudinal case and control adoption study of substance use, at 39 single nucleotide polymorphisms encompassing the GABRA2 locus and analyzed them with respect to their lifetime history of three common forms of substance use dependence [alcohol dependence (AD), nicotine dependence (ND), and cannabis dependence (CD)] in the Iowa Adoption Studies and relevant exposure variables. RESULT: Using regression analysis, we found substantial evidence that both GABRA2 genotype and haplotype are significantly related to vulnerability to AD, ND, and CD, with the strongest relationships noted with respect to ND. Consistent with earlier studies suggesting exposure is an important step in the development of substance use, we found the inclusion of substance exposure data in our analytic models markedly increased the strength of the genetic associations of GABRA2 haplotype with substance use. Finally, we report that the genetic effects were markedly more pronounced in females than in males. CONCLUSION: We conclude that genetic variation at or near the GABRA2 locus significantly affects vulnerability not only to AD, but to other forms of substance use including ND and CD, and that the effects may be sex dependent.
Authors: M T Lynskey; A C Heath; E C Nelson; K K Bucholz; P A F Madden; W S Slutske; D J Statham; N G Martin Journal: Psychol Med Date: 2002-02 Impact factor: 7.723
Authors: Robert A Philibert; Harinder Sandhu; Nancy Hollenbeck; Tracy Gunter; William Adams; Anup Madan Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-07-05 Impact factor: 3.568
Authors: Abigail G Matthews; Eric K Hoffman; Nicholas Zezza; Scott Stiffler; Shirley Y Hill Journal: J Stud Alcohol Drugs Date: 2007-09 Impact factor: 2.582
Authors: Howard J Edenberg; Danielle M Dick; Xiaoling Xuei; Huijun Tian; Laura Almasy; Lance O Bauer; Raymond R Crowe; Alison Goate; Victor Hesselbrock; Kevin Jones; Jennifer Kwon; Ting-Kai Li; John I Nurnberger; Sean J O'Connor; Theodore Reich; John Rice; Marc A Schuckit; Bernice Porjesz; Tatiana Foroud; Henri Begleiter Journal: Am J Hum Genet Date: 2004-03-12 Impact factor: 11.025
Authors: C Mary Schooling; Tai Hing Lam; G Neil Thomas; Benjamin J Cowling; Michelle Heys; Edward D Janus; Gabriel M Leung Journal: PLoS One Date: 2007-10-24 Impact factor: 3.240
Authors: Jennifer A Bailey; Karl G Hill; Meredith C Meacham; Susan E Young; J David Hawkins Journal: Drug Alcohol Depend Date: 2011-06-02 Impact factor: 4.492
Authors: Whitney E Melroy; Sarah H Stephens; Joseph T Sakai; Helen M Kamens; Matthew B McQueen; Robin P Corley; Michael C Stallings; Christian J Hopfer; Kenneth S Krauter; Sandra A Brown; John K Hewitt; Marissa A Ehringer Journal: Behav Genet Date: 2014-04-01 Impact factor: 2.805
Authors: Samuel Kuperman; Grace Chan; John Kramer; Leah Wetherill; Laura Acion; Howard J Edenberg; Tatiana M Foroud; John Nurnberger; Arpana Agrawal; Andrey Anokhin; Andrew Brooks; Victor Hesselbrock; Michie Hesselbrock; Marc Schuckit; Jay Tischfield; Xiangtao Liu Journal: Alcohol Date: 2017-06-28 Impact factor: 2.405
Authors: David A Kareken; Tiebing Liang; Leah Wetherill; Mario Dzemidzic; Veronique Bragulat; Cari Cox; Thomas Talavage; Sean J O'Connor; Tatiana Foroud Journal: Alcohol Clin Exp Res Date: 2010-12 Impact factor: 3.455
Authors: Meredith C Meacham; Jennifer A Bailey; Karl G Hill; Marina Epstein; J David Hawkins Journal: Drug Alcohol Depend Date: 2013-02-19 Impact factor: 4.492
Authors: Ronald L Simons; Leslie Gordon Simons; Man Kit Lei; Steven R H Beach; Gene H Brody; Frederick X Gibbons; Robert A Philibert Journal: J Marriage Fam Date: 2013-04